HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cathepsin S Cleavage of Protease-Activated Receptor-2 on Endothelial Cells Promotes Microvascular Diabetes Complications.

Abstract
Endothelial dysfunction is a central pathomechanism in diabetes-associated complications. We hypothesized a pathogenic role in this dysfunction of cathepsin S (Cat-S), a cysteine protease that degrades elastic fibers and activates the protease-activated receptor-2 (PAR2) on endothelial cells. We found that injection of mice with recombinant Cat-S induced albuminuria and glomerular endothelial cell injury in a PAR2-dependent manner. In vivo microscopy confirmed a role for intrinsic Cat-S/PAR2 in ischemia-induced microvascular permeability. In vitro transcriptome analysis and experiments using siRNA or specific Cat-S and PAR2 antagonists revealed that Cat-S specifically impaired the integrity and barrier function of glomerular endothelial cells selectively through PAR2. In human and mouse type 2 diabetic nephropathy, only CD68(+) intrarenal monocytes expressed Cat-S mRNA, whereas Cat-S protein was present along endothelial cells and inside proximal tubular epithelial cells also. In contrast, the cysteine protease inhibitor cystatin C was expressed only in tubules. Delayed treatment of type 2 diabetic db/db mice with Cat-S or PAR2 inhibitors attenuated albuminuria and glomerulosclerosis (indicators of diabetic nephropathy) and attenuated albumin leakage into the retina and other structural markers of diabetic retinopathy. These data identify Cat-S as a monocyte/macrophage-derived circulating PAR2 agonist and mediator of endothelial dysfunction-related microvascular diabetes complications. Thus, Cat-S or PAR2 inhibition might be a novel strategy to prevent microvascular disease in diabetes and other diseases.
AuthorsSanthosh Kumar Vr, Murthy N Darisipudi, Stefanie Steiger, Satish Kumar Devarapu, Maia Tato, Onkar P Kukarni, Shrikant R Mulay, Dana Thomasova, Bastian Popper, Jana Demleitner, Gabriele Zuchtriegel, Christoph Reichel, Clemens D Cohen, Maja T Lindenmeyer, Helen Liapis, Solange Moll, Emma Reid, Alan W Stitt, Brigitte Schott, Sabine Gruner, Wolfgang Haap, Martin Ebeling, Guido Hartmann, Hans-Joachim Anders
JournalJournal of the American Society of Nephrology : JASN (J Am Soc Nephrol) Vol. 27 Issue 6 Pg. 1635-49 (06 2016) ISSN: 1533-3450 [Electronic] United States
PMID26567242 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2016 by the American Society of Nephrology.
Chemical References
  • RO5461111
  • Receptor, PAR-2
  • Proline
  • Cathepsins
  • cathepsin S
Topics
  • Animals
  • Cathepsins (antagonists & inhibitors, physiology)
  • Cells, Cultured
  • Diabetic Angiopathies (etiology)
  • Endothelial Cells (enzymology)
  • Kidney Glomerulus (cytology)
  • Male
  • Mice
  • Microvessels
  • Proline (analogs & derivatives, pharmacology)
  • Receptor, PAR-2 (metabolism)
  • Urothelium (cytology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: